Franklin Resources’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Franklin Resources’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-65,180	Closed	-$8.04M	–	1542
2017 Q1	$8.04M	Hold	65,180	–	–	﹤0.01%	1011
2016 Q4	$8.88M	Sell	65,180 -3,470	-5%	-$616K	﹤0.01%	990
2016 Q3	$13.7M	Hold	68,650	–	–	0.01%	908
2016 Q2	$8.9M	Hold	68,650	–	–	﹤0.01%	993
2016 Q1	$6.42M	Hold	68,650	–	–	﹤0.01%	1053
2015 Q4	$13.9M	Sell	68,650 -2,700	-4%	-$483K	0.01%	932
2015 Q3	$10.4M	Sell	71,350 -13,680	-16%	-$2.51M	0.01%	1011
2015 Q2	$18.1M	Buy	85,030 +23,020	+37%	+$5.64M	0.01%	908
2015 Q1	$14.4M	Buy	62,010 +47,010	+313%	+$11.4M	0.01%	965
2014 Q4	$3.46M	Buy	+15,000	New	+$3.22M	﹤0.01%	1246

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Franklin Resources's BLCM Position: Q2 2017 in Review

Franklin Resources sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2017, closing a stake of 65,180 shares — an estimated $8.04M sold.

Franklin Resources first reported a position in BLCM in Q4 2014 and held it in 10 quarters. The position peaked at $18.1M in Q2 2015. 84 funds tracked by Wall St. Rank hold BLCM as of Q2 2017.

Franklin Resources reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Franklin Resources sold 65,180 Bellicum Pharmaceuticals, Inc. shares in Q2 2017, an estimated $8.04M.
Franklin Resources first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 10 quarters.
Franklin Resources's Bellicum Pharmaceuticals, Inc. position peaked at $18.1M in Q2 2015.
84 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2017.

Based on Franklin Resources's 13F filing for Q2 2017, filed 10 Aug 2017.